Ra Medical Systems Inc represents values of innovation, quality, and patient care. The company is committed to delivering advanced medical technologies that improve the lives of patients worldwide. With a strong corporate philosophy centered on enhancing treatment options, Ra Medical Systems Inc focuses on developing and commercializing innovative solutions for vascular and dermatological diseases. By prioritizing research and development, the company aims to provide physicians with effective, safe, and minimally invasive treatment options. Through its dedication to excellence and commitment to patient outcomes, Ra Medical Systems Inc strives to be a leader in the field of medical technology, delivering cutting-edge solutions that make a meaningful difference in people's lives.

Ra Medical Systems Inc is primarily present in the United States.

Ra Medical Systems Inc, a leading medical technology company, has achieved several significant milestones. Firstly, the company developed and launched the ground-breaking excimer laser system, Pharos, which revolutionized the treatment of chronic skin diseases with its targeted UVB phototherapy. Secondly, Ra Medical Systems received clearance from the U.S. FDA for its excimer laser system in 2004, opening new avenues for providing effective and safe treatment options. Moreover, in 2017, the company achieved ISO 13485 certification, showcasing its commitment to maintaining high-quality standards in the manufacturing of medical devices. These milestones highlight Ra Medical Systems Inc's commitment to innovation and improving patient outcomes in the field of dermatology.

Ra Medical Systems Inc is a medical device company based in California. Established in 2002, Ra Medical Systems specializes in the development, manufacturing, and commercialization of excimer lasers for the treatment of a wide range of dermatologic and cardiovascular conditions. The company's flagship product, Pharos, is an advanced excimer laser system designed for the therapy of psoriasis, vitiligo, and other skin disorders. Ra Medical Systems has a strong commitment to innovation and patient safety, continuously striving to provide effective and minimally invasive treatment options for patients worldwide. With its cutting-edge technology, Ra Medical Systems Inc has emerged as a prominent player in the medical industry.

The main competitors of Ra Medical Systems Inc in the market include companies such as AngioDynamics, Inc., AngioSculpt, Biolitec AG, Cardiovascular Systems, Inc., and Medtronic Plc.

Ra Medical Systems Inc is primarily active in the medical equipment industry.

Ra Medical Systems Inc. operates as a medical device company that develops and markets excimer lasers for use in the treatment of various dermatological and cardiovascular conditions. The business model of Ra Medical Systems Inc. revolves around providing innovative laser technology solutions to healthcare professionals and institutions worldwide. With a focus on delivering safe, effective, and cost-efficient treatments, the company aims to address the needs of patients suffering from chronic skin diseases and cardiovascular disorders. By developing cutting-edge laser systems and partnering with healthcare providers, Ra Medical Systems Inc. strives to improve medical outcomes and enhance patient care within the medical community.

Ra Medical Systems hissesinin F/K oranı -0,02.

Ra Medical Systems KUV 0,05 dir.

Ra Medical Systems için AlleAktien Kalite Skoru 2/10'dur.

beklenen Ra Medical Systems cirosu 8,81 Milyon. USD dir.

beklenen Ra Medical Systems karı -17,24 Milyon. USD olarak gerçekleşmiştir.

Ra Medical Systems Inc is a US-American company specialized in the development and marketing of innovative technologies for the treatment of vascular diseases. The company has been active since 2002 and is headquartered in Carlsbad, California. Its product range includes the DABRA system and the Pharos system. The DABRA system is a commercially available laser ablation system for the treatment of peripheral atherosclerotic lesions in the arteries. The Pharos system is a non-invasive laser device for the treatment of cutaneous lesions such as psoriasis or vitiligo. The company earns its money through the sale of its medical devices to private clinics and medical facilities domestically and internationally. It also generates revenue through ongoing maintenance and support of its devices. Ra Medical Systems operates its own research and development department specializing in the development of new technologies for the diagnosis and treatment of vascular diseases. The company focuses on developing technologies that offer higher effectiveness and lower risk for patients compared to conventional methods. With a strong distribution network and a presence at international trade shows, Ra Medical Systems is well-positioned to continue operating successfully in the market.

Ra Medical Systems, yılda kez dağıtılmak üzere 0 USD tutarında temettü ödemektedir.

Ra Medical Systems için şu an için temettü hesaplanamıyor veya şirket temettü dağıtmıyor.

Ra Medical Systems şirketinin ISIN kodu US74933X2036’dir.

Ra Medical Systems 'nin WKN'si A2QJCG 'dir.

Ra Medical Systems için Ticker RMED’dir.

Son 12 ay içerisinde Ra Medical Systems, tutarında bir temettü ödedi. Bu, yaklaşık olarak oranında bir temettü verimine denk gelmektedir. Gelecek 12 ay için Ra Medical Systems, tahmini olarak 0 USD tutarında bir temettü ödemesi yapacak.

Ra Medical Systems şirketinin mevcut temettü verimi .

Ra Medical Systems dönemsel olarak temettü ödemesi yapar. Bu ödemeler aylarında gerçekleştirilir.

Ra Medical Systems, son 0 yıl içerisinde her yıl temettü ödedi.

Önümüzdeki 12 ay için 0 USD tutarında temettü ödenmesi beklenmektedir. Bu, 0 % oranında bir temettü verimidir.

Ra Medical Systems, 'Sağlık' sektörüne atanmıştır.

Son Ra Medical Systems tarihinde 0 USD tutarındaki en son temettüyü alabilmek için, hisseyi 01.11.2024 tarihindeki Ex-Tag'den önce portföyünde bulundurman gerekiyordu.

Son ödeme tarihi 01.11.2024 olarak gerçekleşti.

2023 yılında Ra Medical Systems tarafından 0 USD olarak temettüler dağıtıldı.

Ra Medical Systems hisselerinin temettüleri USD olarak dağıtılır.